...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. in South Korea
12/14/16
> Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients
12/14/16
> Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss
12/14/16
> Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line
12/13/16
> RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn's Disease
12/13/16
> RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis
12/12/16
> New Flash Cartridges for Peptide Purification from Biotage
12/07/16
> LifeCodexx Receives CE Mark for its Novel NIPT Solution Based On Methylation-Specific Quantitative PCR
12/07/16
> leon-nanodrugs Partners with Instillo for GMP Production of a MicroJet Reactor (MJR®) Based Formulation of a Generic Oncology Supportive Product
12/07/16
> Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
12/07/16
> Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis Ltd.
12/05/16
> Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility
12/02/16
> New Vetter Data Processing Center is Officially Certified
11/30/16
> Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica
11/29/16
> Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency
11/23/16
> RedHill Biopharma Announces YELIVA™ (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
11/21/16
> Independent Clinical Study Shows Adherium’s Smartinhaler™ Dramatically Improves Clinical Outcomes and Medication Adherence in Children with Asthma
11/17/16
> Zytoprotec Phase II Peritoneal Dialysis Study: Last Patient Out
11/14/16
> Prospective Clinical Follow-Up Study with Over 2,200 Patients Confirms High Test Accuracy of Prenatest® for Fetal Trisomies
11/14/16
> Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
11/14/16
> RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study
11/10/16
> Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston
11/10/16
> PSR Orphan Experts Launches Patient Organization Advisory Board
11/08/16
> Agendia’s Proven Breast Cancer Recurrence Assay, MammaPrint, Now Available in the Middle East
11/08/16
> AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development
11/08/16
> Changes in the AYOXXA Management Team
11/07/16
> AdAlta and XL-protein Announce Collaboration to Develop a Long Acting Version of Its Lead Fibrosis Drug Candidate AD-114 Using PASylation® Technology
11/07/16
> Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine
11/07/16
> Atriva Therapeutics Announces Upcoming US Patent Issuance for MEK Treatment against Viral Diseases
11/04/16
> ARTES and BioSun Announce Co-Development for HPV Vaccine
11/04/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 4 of 48